Patients with pure COPD had a higher 6MWT, a lower Charlson comorbidity index, a lower NT-proBNP, and a higher Hs-CRP compared with all the CHF patients (Table 2). This evidence concerns the gene NPPB and chronic obstructive pulmonary disease.